Harnessing silicon nanoparticles to fight infections

June 5, 2018, University of Minnesota

There is an urgent need for better methods to treat bacterial infection in the race between developing new antibiotics and the emergence of drug-resistant bacteria.

Presently, antimicrobial resistance is responsible for 23,000 deaths annually in the United States and 700,000 deaths worldwide. A Wellcome Trust 2016 study predicted the present rate of emergence of new virulent strains will outstrip the U.S. Food and Drug Administration approval rate for new antimicrobial agents by 2050—which means deaths from antimicrobial resistant strains will exceed deaths from cancer.

University of Minnesota researcher Hongbo Pang assisted in discovering the first example of an effective gene therapeutic against lethal bacterial infections using a nanotherapeutic to deliver short interfering RNA (siRNA) that targets immune system . This research, published in the journal Nature Communications, was conducted by a team from the University of Minnesota; University of California, San Diego (UCSD); Sanford Burnham Medical Discovery Institute (SBMDI); and the Korea Advanced Institute of Science and Technology (KAIST).

"This study perfectly demonstrates the great potential of targeted nanotechnology in treating various human diseases," said Pang, an assistant professor in the University of Minnesota College of Pharmacy.

"This is a really great example of convergent research," said Michael Sailor from the University of California, San Diego. "To get this concept to work, we needed to combine our nanomaterials expertise at UCSD and the membrane and cell biology expertise at KAIST with the peptides and disease models developed by our biomedical collaborators at the SBMDI and UMN."

The research team further explored gene therapeutic, an under-utilized approach to fight bacterial infections and to bolster the body's immune system. siRNA gene therapeutics are able to enhance the ability of some innate immune cells to attack bacteria while shutting down the immune system's inflammatory response that can interfere with recovery.

With this treatment, the hope is a wide range of bacterial infections, including emerging strains, can be attacked. While delivering siRNA in the body is notoriously difficult, the study found siRNA therapy produced a full recovery from a lethal bacterial by rescuing 100 percent of mice infected with a lethal dose of Staph. aureus pneumonia.

"A short strand of peptide can recognize macrophages, an important immune cell type, selectively in the infection site," added Pang. "In combination with nanomaterial of unique advantages as drug carriers, we could deliver gene therapeutics efficiently to where they are needed, and achieve a full recovery from a lethal bacterial infection."

The research team incorporated three features into their nanoparticle design:

  • generated a porous nanoparticle host that protected its siRNA payload from premature degradation in the bloodstream;
  • discovered a peptide that selectively targets , a type of white blood cell which attacks foreign microbes and signals an invader is present
  • engineered a chemical coating, called a fusogenic lipid, that allowed the nanoparticle to penetrate into the macrophage and deliver its gene therapeutic to the proper compartments in the cell.

According to Pang, the study is the first example of an effective gene therapy for lethal bacterial infections, using a nanotherapeutic to deliver siRNA to target macrophage cells. The research team, for the first time, have demonstrated that siRNA therapeutic can generate a full recovery from a lethal bacterial infection.

Explore further: Antibiotic nanoparticles fight drug-resistant bacteria

More information: Byungji Kim et al. Immunogene therapy with fusogenic nanoparticles modulates macrophage response to Staphylococcus aureus, Nature Communications (2018). DOI: 10.1038/s41467-018-04390-7

Related Stories

Antibiotic nanoparticles fight drug-resistant bacteria

July 12, 2017

Antibiotic resistance is a growing problem, especially among a type of bacteria that are classified as "Gram-negative." These bacteria have two cell membranes, making it more difficult for drugs to penetrate and kill the ...

Deadly bacteria stiff-arm the immune system

October 14, 2015

The most severe Group A Streptococcus (strep) infections are often the work of one particularly nefarious strain known as M1T1, named in part for the type of tentacle-like M protein projecting from the bacterium's surface. ...

Macrophage nanosponges could keep sepsis in check

January 4, 2018

A team of researchers at the University of California San Diego has developed macrophage "nanosponges" that can safely absorb and remove molecules from the bloodstream that are known to trigger sepsis. These macrophage nanosponges, ...

Addressing superbug resistance with phage therapy

August 16, 2017

International research involving a Monash biologist shows that bacteriophage therapy – a process whereby bacterial viruses attack and destroy specific strains of bacteria - can be used successfully to treat systemic, multidrug ...

Recommended for you

Meteorite source in asteroid belt not a single debris field

February 17, 2019

A new study published online in Meteoritics and Planetary Science finds that our most common meteorites, those known as L chondrites, come from at least two different debris fields in the asteroid belt. The belt contains ...

Diagnosing 'art acne' in Georgia O'Keeffe's paintings

February 17, 2019

Even Georgia O'Keeffe noticed the pin-sized blisters bubbling on the surface of her paintings. For decades, conservationists and scholars assumed these tiny protrusions were grains of sand, kicked up from the New Mexico desert ...

Archaeologists discover Incan tomb in Peru

February 16, 2019

Peruvian archaeologists discovered an Incan tomb in the north of the country where an elite member of the pre-Columbian empire was buried, one of the investigators announced Friday.

Where is the universe hiding its missing mass?

February 15, 2019

Astronomers have spent decades looking for something that sounds like it would be hard to miss: about a third of the "normal" matter in the Universe. New results from NASA's Chandra X-ray Observatory may have helped them ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.